Budapest, Hungary

Géza Schneider

This inventor holds 1 USPTO granted patent. Top assignees: Cf Pharma Gyogyszergyarto Kft., Helm Ag. Active years: 2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Géza Schneider. Retrieved from https://idiyas.com/inventor/géza-schneider

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2008

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Géza Schneider

Introduction

Géza Schneider is a notable inventor based in Budapest, Hungary. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative processes. His work has led to the development of important compounds that have potential applications in medicine.

Latest Patents

Schneider holds a patent for a process related to the preparation of N-(4'-cyano-3′-trifluoromethylphenyl)-3-(4″-fluorophenylsulfonyl)-2-hydroxy-2-methylpropionamide, commonly known as bicalutamide. This invention is crucial in the synthesis of a compound that has therapeutic implications.

Career Highlights

Throughout his career, Schneider has worked with various companies, including Helm AG and CF Pharma Gyógyszergyártó Kft. His experience in these organizations has allowed him to refine his skills and contribute to significant advancements in pharmaceutical processes.

Collaborations

Some of Schneider's notable coworkers include Ádám Bor and György Orosz. Their collaboration has likely fostered an environment of innovation and creativity in their respective projects.

Conclusion

Géza Schneider's contributions to the field of pharmaceuticals through his patent and collaborations highlight his role as an influential inventor. His work continues to impact the industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…